# Amarin Pharma Inc. – FDA Inspection, Aug 2, 2019

Source: https://www.keypedia.com/records/fda_inspections/amarin-pharma-inc/58d0bbde-fcdf-427f-9577-b5c13653b8f2
Source feed: FDA_Inspections

> FDA inspection 1100373 of Amarin Pharma Inc., August 02, 2019. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1100373
- Company Name: Amarin Pharma Inc.
- Inspection Date: 2019-08-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 891859 - 2014-09-09](https://www.keypedia.com/records/fda_inspections/amarin-pharma-inc/c337313d-d9e6-4330-adeb-c63f6f86af67)
- FDA Inspection 854226 - 2013-10-29

## Related Officers

- [Byungja E. Marciante](https://www.keypedia.com/people/byungja-e-marciante/5d1f2927-9017-4ab6-8ad2-521e340ef14f)
- [Company Rep](https://www.keypedia.com/people/nina-yang/8d080437-2e05-4b75-8c53-b818d761cf1f)

Company: https://www.keypedia.com/companies/amarin-pharma-inc/dd301a42-2e08-4db9-929f-eaf4891ffad7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c